It's usually similar to what you'd see on an exchange stock that moved 30% in a day( 5-10 times normal volume). Look at MDLH today. It's a Pink sheet up 575%.
There is no such thing as a "market" here - just some uneducated, stupid, or confused people who sell. The stock price only represents the last person who sold. That's why stocks trading at OTCC or on the Pinks often jump 600-700% in a day. Tou should go to OTCC or Pink websites and look at greatest movers every day. I've been trading in Pinks and OTCC for many, many years and have seen unbelieveble moves up tat you will never see on an exchange. How many stocks on the Nasdaq or NYSE have you seen gain 700% in a day? You saw that list of Pink sheet stocks I posted that moved hundreds of percents on just that one day. It will happen here. Anyone selling is nuts.
At Ameritrade they are the same as any other exchange, and regardless of the quantity bought, it's the same low price (most people are $9.95 but I have a negotiated rate). Pink sheet stocks are also the same regardless of quanity. I'm hoping this moves to the pink sheets because it will really jump up if there is any good news or if they file.(people don't fade the pinks as readily) Stocks move to the Pinks if they don't quickly file. If they later file they can move back.
They are guarantors of the HSBC loans. Blackstone is taking over these loans and Cyprus and Greece will be released, but they have to be shown on the form.
How about BLOAQ? This is from a Forbes article:" I then pulled up a multi-day chart and saw that BLOAQ had exploded from a September 19th price of about 7 cents to today’s range of 20 to 30 cents. The liquidating shares of Blockbuster have nearly quadrupled in about ten days. Of course, it’s a tad odd to have a sentence with “liquidating shares” of a bankrupt company coupled with the “nearly quadrupled” result of the stock’s recent share price."
Ha, Ha! You made it so narrow that you thought nothing would qualify, but there are tons of companies. There are very few foreign companies on OTCBB. Here are two domestic that come to mind that were totally broke and sold assets - most people don't even realize that they are OTCBB stocks - FNMA and FMCC - both went up 10 fold after being on OTCBB. Here's a bankrupt one, sold assets, that doubled - XIDEQ. Here is that foreign one that meets all your requirements: PTQMF. It was totally broke and sold off almost all assets and, after going on OTCBB, it went from 5 cents to $3.35!!!! You are a negative Nellie who doesn't understand the stock market. The price of a security has nothing to do with it's value. Price only reflects the thinking & fears of the last person who sold. Ultimately the value of a company's assets and earnings come out when people sober up. That's why I will take your money.
Now we know why this closed down today at the close - the nasdaq specialist had to dump the inventory he was holding because he's no longer involved with the stock.
This did not close on low of day. It closed at .0685 in the last hundredth of a second - those other transactions were crossed by the Nasdaq specialist from earlier in the day.
I'm going to love taking your money. I took it from you in many other stocks after they crashed (like BCRX) and I'll take it from you here.
"Additionally, the businesses not included in the current proposed sale agreement continue to grow and deliver improved results. Velti's Performance Mobile Marketing Business will also continue to provide services to the businesses named in the current purchase agreement " Thanks for the shares at this terrific price!
Come on and get real. Roche got Xenical approved in Europe and is selling it there. There isn't a more dangerous or sleazier drug on the market than that!
I think Roche didn't want to put up as much as AENA wanted so Eisai stepped in and put up the upfront money and Roche will walk this through EMA and co-market for part of the split. That's why they had to lower Arena's share. Roche & Eisai have a collaboration going already: CAMBRIDGE, Mass., Jan. 7, 2013 /PRNewswire/ -- Epizyme, Inc., a biopharmaceutical company leading the creation of personalized therapeutics to treat patients with genetically defined cancers, Eisai Co., Ltd. (ESALY) and Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today a collaboration to develop an in vitro PCR (Polymerase Chain Reaction) based companion diagnostic test. The collaboration's goal is to identify lymphoma patients with non-wild type EZH2, including the Y641 mutation. As demonstrated in Epizyme's Nature Chemical Biology publication, "A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells [link]," lymphomas with genetic alterations of EZH2 require EZH2 enzymatic activity for proliferation, suggesting that EZH2 is a driving oncogene in these cancers and therefore an important therapeutic target
Chantix generated $720 million in sales last year for Pfizer At that level Ratio becomes .365 and translates into $262.8 million to Arena plus milestones of $95.5 million for annual total revenue of $358.3 million or Earnings of .71 a share X18(biotech PE) = $12.75 a share. It would be just fine if it sells like Chantix.
Also you left out Xenical, with over $500 million in annual sales about to be pulled from market. Also you left out Bel Phen.
You left out Euro partner being announced, you left out 1,000 doctors giving lectures. You left out increase in sales force, some have already hit the field. You left out insurance just went to 40% and headed to 50% by year end (per Eisai CC). You left out 10,000 doctors now scripting. You left out DTC advertising just started and TV about to start. You left out Mexico approval about to be announced with Korea and Taiwan right behind. You left out $112 million in milestones and collaborations coming. You left out their other drugs are now at point a partner and upfront payments could be announced at any moment. You left out the bill in Congress.